Biomedical R&D in Brazil: who owns IP rights?
Denise Golgher, biotechnology specialist, published on “The Legal 500” the article “Biomedical R&D in Brazil: who owns IP rights?”. The article analyzes the scenario of increasing innovation in the Brazilian healthcare sector, as based on recent continuing investments, and emphasizes how those involved should give active consideration to IP rights, particularly to the ownership of such rights. Read the full article at: https://www.legal500.com/developments/thought-leadership/biomedical-rd-in-brazil-who-owns-ip-rights/
RECENT PUBLICATIONS
-
O Direito à compensação in natura em razão da mora administrativa injustificada: Abordagem da responsabilidade civil estatal na condução dos processos administrativos de concessão de patentes
4月 09, 2026 -
InterDigital posts record smartphone revenue in 2025
2月 06, 2026 -
ZTE defeats Samsung again as Brazilian appeals court reinstates 5G injunction, declines to give Samsung “free pass to infringe” and hold out
2月 04, 2026